Scientists have sequenced the oldest RNA from a 40,000-year-old mammoth named Yuka, unlocking genetic activity from its final ...

mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...

CereCura was co-founded by renowned scientist and UBC professor Pieter Cullis, who developed LNPs, the drug delivery system ...

The well-preserved remains of a woolly mammoth found in Siberia enabled scientists to extract RNA for the first time and ...

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...

“Enteromix is an oncolytic vaccine made from a mixture of enteroviruses that selectively infect tumour cells and stimulate ...

Now, there’s a new player in town called CancerVax, and it’s getting a lot of attention. This article is going to look at ...

Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North ...

Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.